INT198357

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.03
First Reported 2006
Last Reported 2006
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 1
Disease Relevance 0.51
Pain Relevance 0.17

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular space (Igf1) extracellular region (Igf1)
Igf1 (Mus musculus)
Pain Link Frequency Relevance Heat
Somatostatin 14 99.50 Very High Very High Very High
imagery 1 94.12 High High
tolerance 2 81.60 Quite High
agonist 2 72.08 Quite High
Pain 4 5.00 Very Low Very Low Very Low
headache 3 5.00 Very Low Very Low Very Low
visual analogue scale 2 5.00 Very Low Very Low Very Low
abdominal pain 2 5.00 Very Low Very Low Very Low
antagonist 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Acromegaly 24 97.04 Very High Very High Very High
Cancer 4 92.76 High High
Impaired Glucose Tolerance 1 81.60 Quite High
Adenoma 3 25.68 Quite Low
Disease 2 8.00 Low Low
Pain 4 5.00 Very Low Very Low Very Low
Skin Appendage Disease 3 5.00 Very Low Very Low Very Low
Headache 3 5.00 Very Low Very Low Very Low
Abdominal Pain 2 5.00 Very Low Very Low Very Low
Diarrhoea 2 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Eligible patients had responded to somatostatin analogues, defined as a reduction in GH of 50% or more from baseline, normalization of IGF-1 or a reduction of 30% or more, after a minimum period of 2 months of treatment.
Negative_regulation (reduction) of Localization (normalization) of IGF-1 associated with somatostatin
1) Confidence 0.03 Published 2006 Journal Clinical Endocrinology Section Body Doc Link PMC1618957 Disease Relevance 0.51 Pain Relevance 0.17

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox